Latest News

  • Hesperos wins grant to tackle drug-induced dementia

    Hesperos has been awarded a NIA Phase IIB SBIR grant to study how combinations of medicines raise the risk of drug-induced dementia in older adults. In partnership with GalenusRx, the company will use its Human-on-a-Chip (HoaC) multi-organ systems to examine how certain medicines interact and may drive cognitive decline. The technology uses miniature organ systems [...]

  • Most Americans would be considered obese under new guidelines

    Almost 70 per cent of US adults would be classified as having obesity under a new definition proposed by medical experts — a major increase from 43 per cent using current BMI standards. The proposed obesity definition expands beyond body mass index (BMI) to include waist measurements and body fat scans, identifying many more people [...]

  • Nila raises US$2.4m for cross-border elder care

    Nila has raised US$2.4m (£1.8m) to scale its elder care platform in India and prepare expansion to other Asian markets. The pre-seed round was led by LocalGlobe, with participation from Redbus Ventures and high-net-worth and angel investors from remittance, fintech and healthtech, including investors from Nala, Revolut and Wise. Nila plans to expand across India [...]

  • Cairns buys AI health app Together by Renee

    Cairns Health has acquired AI app Together by Renee and will fold its medication tech into Luna to support older adults and people with chronic conditions. Together by Renee uses computer vision (software that reads images) to scan pill labels for reminders and refills, and “agentic” AI (systems that act toward a goal) to automate [...]

  • New US$6.5m centre targets healthy ageing

    A new Los Angeles research centre, funded with US$6.5m over five years, aims to advance healthy ageing and help older adults live more independently. The National Institute on Aging has awarded the grant to create the Los Angeles Claude D. Pepper Older Americans Independence Center (LA OAIC). The centre is a collaboration among Cedars-Sinai, the [...]

  • FDA greenlights simple Alzheimer’s test

    The US Food and Drug Administration (FDA) has approved a second blood test to detect Alzheimer's disease, potentially speeding diagnosis for millions of patients. The Elecsys pTau181 test measures protein levels in blood plasma that act as biomarkers for the degenerative brain disorder, offering a simpler alternative to costly brain scans for people aged 55 [...]

  • Georgia centre wins funding for falls prevention

    A research centre has secured nearly US$150,000 to support falls prevention for older adults in Georgia through a statewide coalition. The Injury Prevention Research Center at Emory (IPRCE) is one of 12 organisations to receive funding from the National Council on Aging and the Administration for Community Living to strengthen Georgia’s falls prevention coalition. The [...]

  • Roundup: Atlas maps molecular fingerprints of health, disease and ageing

    Age Tech World explores the latest research developments in the world of ageing and longevity. Pan-disease atlas maps molecular fingerprints of health, disease and ageing A new study has mapped the distinct molecular “fingerprints” that 59 diseases leave in an individual’s blood protein, which would enable blood tests to discern troubling signs from those that [...]

  • Cholesterol-lowering drugs could reduce dementia risk

    People with genetic variants that naturally lower cholesterol were found to have up to 80 per cent lower dementia risk in a study of more than one million participants. The research analysed data from Denmark, England and Finland to assess how genes that mimic the effects of cholesterol-lowering drugs such as statins and ezetimibe influence [...]

  • New drug enhances GLP-1 weight loss without extra added effects, trial finds

    Nimacimab significantly enhanced weight loss when combined with GLP-1 therapy without adding side effects, according to mid-stage clinical trial results involving 136 adults. The experimental drug targets the body’s endocannabinoid system differently from existing weight-loss medications, offering a potential new approach to treating obesity when used alongside drugs such as semaglutide. Participants given both drugs [...]